Depakote - 54868-2544-3 - (divalproex sodium)

Alphabetical Index


Drug Information of Depakote

Product NDC: 54868-2544
Proprietary Name: Depakote
Non Proprietary Name: divalproex sodium
Active Ingredient(s): 500    mg/1 & nbsp;   divalproex sodium
Administration Route(s): ORAL
Dosage Form(s): TABLET, DELAYED RELEASE
Coding System: National Drug Codes(NDC)

Labeler Information of Depakote

Product NDC: 54868-2544
Labeler Name: Physicians Total Care, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA018723
Marketing Category: NDA
Start Marketing Date: 19940817

Package Information of Depakote

Package NDC: 54868-2544-3
Package Description: 20 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC (54868-2544-3)

NDC Information of Depakote

NDC Code 54868-2544-3
Proprietary Name Depakote
Package Description 20 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC (54868-2544-3)
Product NDC 54868-2544
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name divalproex sodium
Dosage Form Name TABLET, DELAYED RELEASE
Route Name ORAL
Start Marketing Date 19940817
Marketing Category Name NDA
Labeler Name Physicians Total Care, Inc.
Substance Name DIVALPROEX SODIUM
Strength Number 500
Strength Unit mg/1
Pharmaceutical Classes Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE],Mood Stabilizer [EPC]

Complete Information of Depakote


General Information